Wordt geladen...
Moving towards efficient therapies in type 1 diabetes: To combine or not to combine?
Every year, thirty thousand people worldwide are diagnosed with type 1 diabetes mellitus (T1DM). T1DM, also called autoimmune diabetes, is a multifactorial disease affecting predisposed individuals and involving genetic susceptibilities, environmental triggers, as well as unbalanced immune responses...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2006
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1896372/ https://ncbi.nlm.nih.gov/pubmed/17412305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.autrev.2006.09.013 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|